266 related articles for article (PubMed ID: 29431598)
1. Momordica charantia Administration Improves Insulin Secretion in Type 2 Diabetes Mellitus.
Cortez-Navarrete M; Martínez-Abundis E; Pérez-Rubio KG; González-Ortiz M; Méndez-Del Villar M
J Med Food; 2018 Jul; 21(7):672-677. PubMed ID: 29431598
[TBL] [Abstract][Full Text] [Related]
2. Momordica charantia reverses type II diabetes in rat.
Malekshahi H; Bahrami G; Miraghaee S; Ahmadi SA; Sajadimajd S; Hatami R; Mohammadi B; Keshavarzi S
J Food Biochem; 2019 Nov; 43(11):e13021. PubMed ID: 31441956
[TBL] [Abstract][Full Text] [Related]
3. The effect of Momordica charantia capsule preparation on glycemic control in type 2 diabetes mellitus needs further studies.
Dans AM; Villarruz MV; Jimeno CA; Javelosa MA; Chua J; Bautista R; Velez GG
J Clin Epidemiol; 2007 Jun; 60(6):554-9. PubMed ID: 17493509
[TBL] [Abstract][Full Text] [Related]
4. Differential anti-diabetic effects and mechanism of action of charantin-rich extract of Taiwanese Momordica charantia between type 1 and type 2 diabetic mice.
Wang HY; Kan WC; Cheng TJ; Yu SH; Chang LH; Chuu JJ
Food Chem Toxicol; 2014 Jul; 69():347-56. PubMed ID: 24751968
[TBL] [Abstract][Full Text] [Related]
5. Anti-hyperglycemic effects of propolis or metformin in type 2 diabetes mellitus.
Ochoa-Morales PD; González-Ortiz M; Martínez-Abundis E; Pérez-Rubio KG; Patiño-Laguna ADJ
Int J Vitam Nutr Res; 2023 Dec; 93(6):498-506. PubMed ID: 35965421
[No Abstract] [Full Text] [Related]
6. Gastro-Resistant Insulin Receptor-Binding Peptide from Momordica charantia Improved the Glucose Tolerance in Streptozotocin-Induced Diabetic Mice via Insulin Receptor Signaling Pathway.
Lo HY; Li CC; Chen FY; Chen JC; Hsiang CY; Ho TY
J Agric Food Chem; 2017 Oct; 65(42):9266-9274. PubMed ID: 28994284
[TBL] [Abstract][Full Text] [Related]
7. Diabetes remission and insulin secretion after gastric bypass in patients with body mass index <35 kg/m2.
Lee WJ; Chong K; Chen CY; Chen SC; Lee YC; Ser KH; Chuang LM
Obes Surg; 2011 Jul; 21(7):889-95. PubMed ID: 21499957
[TBL] [Abstract][Full Text] [Related]
8. Momordica charantia extracts ameliorate insulin resistance by regulating the expression of SOCS-3 and JNK in type 2 diabetes mellitus rats.
Ma C; Yu H; Xiao Y; Wang H
Pharm Biol; 2017 Dec; 55(1):2170-2177. PubMed ID: 29110587
[TBL] [Abstract][Full Text] [Related]
9. Changes in insulin sensitivity and insulin secretion with the sodium glucose cotransporter 2 inhibitor dapagliflozin.
Mudaliar S; Henry RR; Boden G; Smith S; Chalamandaris AG; Duchesne D; Iqbal N; List J
Diabetes Technol Ther; 2014 Mar; 16(3):137-44. PubMed ID: 24237386
[TBL] [Abstract][Full Text] [Related]
10. Slow acting protein extract from fruit pulp of Momordica charantia with insulin secretagogue and insulinomimetic activities.
Yibchok-anun S; Adisakwattana S; Yao CY; Sangvanich P; Roengsumran S; Hsu WH
Biol Pharm Bull; 2006 Jun; 29(6):1126-31. PubMed ID: 16755004
[TBL] [Abstract][Full Text] [Related]
11. Momordica charantia for type 2 diabetes mellitus.
Ooi CP; Yassin Z; Hamid TA
Cochrane Database Syst Rev; 2012 Aug; (8):CD007845. PubMed ID: 22895968
[TBL] [Abstract][Full Text] [Related]
12. Synergistic antidiabetic activity of Taraxacum officinale (L.) Weber ex F.H.Wigg and Momordica charantia L. polyherbal combination.
Perumal N; Nallappan M; Shohaimi S; Kassim NK; Tee TT; Cheah YH
Biomed Pharmacother; 2022 Jan; 145():112401. PubMed ID: 34785415
[TBL] [Abstract][Full Text] [Related]
13. Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus.
Kim SK; Jung J; Jung JH; Yoon N; Kang SS; Roh GS; Hahm JR
Complement Ther Med; 2020 Aug; 52():102524. PubMed ID: 32951763
[TBL] [Abstract][Full Text] [Related]
14. Suppressive activity of the fruit of Momordica charantia with exercise on blood glucose in type 2 diabetic mice.
Miura T; Itoh Y; Iwamoto N; Kato M; Ishida T
Biol Pharm Bull; 2004 Feb; 27(2):248-50. PubMed ID: 14758046
[TBL] [Abstract][Full Text] [Related]
15. Effect of
Gaytán Martínez LA; Sánchez-Ruiz LA; Zuñiga LY; González-Ortiz M; Martínez-Abundis E
J Med Food; 2021 Jan; 24(1):28-32. PubMed ID: 32460589
[No Abstract] [Full Text] [Related]
16. Safety and efficacy of Momordica charantia Linnaeus in pre-diabetes and type 2 diabetes mellitus patients: a systematic review and meta-analysis protocol.
Peter EL; Deyno S; Mtewa A; Kasali FM; Nagendrappa PB; Sesaazi D; Tolo CU; Ogwang PE
Syst Rev; 2018 Nov; 7(1):192. PubMed ID: 30442186
[TBL] [Abstract][Full Text] [Related]
17. Effect of Chlorogenic Acid Administration on Glycemic Control, Insulin Secretion, and Insulin Sensitivity in Patients with Impaired Glucose Tolerance.
Zuñiga LY; Aceves-de la Mora MCA; González-Ortiz M; Ramos-Núñez JL; Martínez-Abundis E
J Med Food; 2018 May; 21(5):469-473. PubMed ID: 29261010
[TBL] [Abstract][Full Text] [Related]
18. Dose-response effect of pioglitazone on insulin sensitivity and insulin secretion in type 2 diabetes.
Miyazaki Y; Matsuda M; DeFronzo RA
Diabetes Care; 2002 Mar; 25(3):517-23. PubMed ID: 11874940
[TBL] [Abstract][Full Text] [Related]
19. Lower hypoglycemic but higher antiatherogenic effects of bitter melon than glibenclamide in type 2 diabetic patients.
Inayat U Rahman ; Khan RU; Khalil Ur Rahman ; Bashir M
Nutr J; 2015 Jan; 14():13. PubMed ID: 25623883
[TBL] [Abstract][Full Text] [Related]
20. Acute and short-term administration of a sulfonylurea (gliclazide) increases pulsatile insulin secretion in type 2 diabetes.
Juhl CB; Pørksen N; Pincus SM; Hansen AP; Veldhuis JD; Schmitz O
Diabetes; 2001 Aug; 50(8):1778-84. PubMed ID: 11473038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
